CHRISTINA LAKE CANNABIS (CLB) - Net Assets

Latest as of November 2025: €16.84 Million EUR

Based on the latest financial reports, CHRISTINA LAKE CANNABIS (CLB) has net assets worth €16.84 Million EUR as of November 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€28.02 Million) and total liabilities (€11.18 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €16.84 Million
% of Total Assets 60.11%
Annual Growth Rate 3.49%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 31.96

CHRISTINA LAKE CANNABIS - Net Assets Trend (2021–2024)

This chart illustrates how CHRISTINA LAKE CANNABIS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for CHRISTINA LAKE CANNABIS (2021–2024)

The table below shows the annual net assets of CHRISTINA LAKE CANNABIS from 2021 to 2024.

Year Net Assets Change
2024-11-30 €10.79 Million +44.67%
2023-11-30 €7.46 Million -33.01%
2022-11-30 €11.14 Million +14.36%
2021-11-30 €9.74 Million --

Equity Component Analysis

This analysis shows how different components contribute to CHRISTINA LAKE CANNABIS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 449537100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (November 2024)

Component Amount Percentage
Other Components €28.24 Million 261.65%
Total Equity €10.79 Million 100.00%

CHRISTINA LAKE CANNABIS Competitors by Market Cap

The table below lists competitors of CHRISTINA LAKE CANNABIS ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in CHRISTINA LAKE CANNABIS's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 7,461,508 to 10,794,256, a change of 3,332,748 (44.7%).
  • Net income of 864,995 contributed positively to equity growth.
  • New share issuances of 1,869,901 increased equity.
  • Other factors increased equity by 597,852.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income €865.00K +8.01%
Share Issuances €1.87 Million +17.32%
Other Changes €597.85K +5.54%
Total Change €- 44.67%

Book Value vs Market Value Analysis

This analysis compares CHRISTINA LAKE CANNABIS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.23x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2021-11-30 €0.08 €0.01 x
2022-11-30 €0.09 €0.01 x
2023-11-30 €0.06 €0.01 x
2024-11-30 €0.06 €0.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently CHRISTINA LAKE CANNABIS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 8.01%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 6.36%
  • • Asset Turnover: 0.58x
  • • Equity Multiplier: 2.16x
  • Recent ROE (8.01%) is above the historical average (-34.73%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2021 -73.34% -196.59% 0.19x 1.96x €-8.12 Million
2022 -18.21% -20.13% 0.54x 1.69x €-3.14 Million
2023 -55.38% -35.08% 0.74x 2.14x €-4.88 Million
2024 8.01% 6.36% 0.58x 2.16x €-214.43K

Industry Comparison

This section compares CHRISTINA LAKE CANNABIS's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $870,348,650
  • Average return on equity (ROE) among peers: -117.72%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
CHRISTINA LAKE CANNABIS (CLB) €16.84 Million -73.34% 0.66x $3.92 Million
Blueberries Medical Corp (1OA) $-70.38K 0.00% 0.00x $1.16 Million
26U (26U) $6.75 Million -514.32% 1.08x $128.79 Million
27N0 (27N0) $2.39 Million -414.95% 0.12x $566.23K
iAnthus Capital Holdings Inc (2IA) $17.51 Million -28.88% 0.14x $4.08 Million
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) $7.85 Billion 28.40% 0.37x $635.99 Million
Revive Therapeutics Ltd (31R) $821.12K -218.10% 0.36x $397.77K
AYR WELLNESS INC.RES.VTG. (3KJB) $835.32 Million -29.39% 1.12x $5.84 Million
Vibe Growth Corporation (3ST) $-5.22 Million 0.00% 0.00x $214.59K
AYURCANN HOLDINGS CORP. (3ZQ0) $-2.95 Million 0.00% 0.00x $113.81K
LORDS CO. WORLDW. HOLD. (4XM) $-1.01 Million 0.00% 0.00x $134.78K

About CHRISTINA LAKE CANNABIS

F:CLB Germany Drug Manufacturers - Specialty & Generic
Market Cap
$3.92 Million
€3.35 Million EUR
Market Cap Rank
#32634 Global
#4655 in Germany
Share Price
€0.01
Change (1 day)
+0.00%
52-Week Range
€0.01 - €0.05
All Time High
€0.70
About

Christina Lake Cannabis Corp., a license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada. It offers distilled and winterized oils; kief products; and additional extracted products. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 2018. Christin… Read more